$4.17
0.266.65%
Last update: Nov 9, 8:39 AM
Abeona Therapeutics Inc
ABEONASDAQ
The average analyst price target for Abeona Therapeutics is $19.88, 427.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $15 to $30. The latest change came on Sep 18, 2026, when Cantor Fitzgerald raised its price target on Abeona Therapeutics from $28 to $30 and kept an Overweight rating.
Price Target Range — 10 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
